North America Microarray Analysis Market

North America Microarray Analysis Market Size & Growth (2023 to 2028)

The size of the North America Microarray Analysis Market is predicted to reach USD 1.9 billion by 2028 from 2023 to 2028.

DNA microarrays are best recognized for their usage in screening, but they've also accelerated illness research. They can distinguish between healthy tissue and malignant tissue. The demand for items used in the analysis is expected to rise due to the growing number of microarray applications. Only cDNA microarrays can be utilized for gene expression analysis; however, oligonucleotide microarrays can be used for mutation-genotyping and gene expression analysis.

The advancement of diagnosis and treatment options has led to creating items that can assist patients in a wide range of situations. Genomic Medicine in Emerging Economies, a book published in 2018, explains how improvements in medical research have already revolutionized health systems and enhanced patient care. Major firms like Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina, and Bio-Rad Laboratories, Inc. have developed new products in recent years as the external business climate has changed due to increased demand from researchers and physicians.

As a result of the pandemic, new products have been approved under the Emergency Use Authorization (EUA) designation. Microarray technology's burgeoning applications and the growing patient population suffering from various diseases are expected to drive up demand for testing and research.

The market for microarray analysis in North America is hampered by the availability of replacements and the advent of other mediums for analysis. Microarray study, for example, only profiles specific transcripts/genes through hybridization, but RNA-sequencing allows for comprehensive sequencing of the entire transcriptome. In addition, the market's expansion is hampered by a scarcity of qualified specialists and the necessity for database standardization.

From raw material procurement through production, packaging, and distribution, the COVID-19 pandemic has disrupted the worldwide supply chain and affected the whole value chain of the North American microarray analysis business. The impact appears to be minimal for a short time because several factories have the essential raw materials and end-product inventories. However, the damage will increase if the pandemic continues and trade restrictions are extended.

This research report on the North America Microarray Analysis Market has been segmented and sub-segmented based on the categories.

By Product:

• Consumables
• Instruments
• Software and Services

By Type:

• DNA Microarrays
• Protein Microarrays
• Others

By Application:

• Research Applications
• Drug Discovery
• Disease Diagnostics
• Others

By End User:

• Research and Academic Institutes
• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• Others

By Country:

• U.S
• Canada
• Rest of North America

Geographically, the North Americas held the most significant market share of 40.98 percent in 2019 and are expected to continue to dominate the worldwide microarray analysis market over the projected period. The increasing adoption of new technologies and big players in the region are responsible for the region's largest market share.

Furthermore, increased commercial application of biochips, growth of personalized medicine, favorable regulatory approval for customized treatment, and increased application of proteomics and genomics in cancer research are the major factors driving the North American lab-on-a-chip and microarrays (biochip) market. Furthermore, the increasing frequency of chronic diseases is expected to drive market growth.

The U.S. microarray analysis market is being propelled forward by the rising prevalence of cancer in this region and increased funding for research and development. 

In 2019, the National Institute of Cancer, for example, received around USD 42.1 in funding for cancer research. Microarrays are used to identify cancer cells and assess their genomic structure. 

The Canadian microarray analysis market is expected to grow significantly due to increased funding for proteomics and genomics and the increased need for innovative pharmaceuticals, which have aided the growth of the North American microarray analysis industry.

KEY MARKET PLAYERS

Promising companies leading the North America microarray analysis market profiled in the report are Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Molecular Devices (U.S.), PerkinElmer Inc. (U.S.), Illumina, Inc. (U.S.), G.E. Healthcare (U.S.), and Bio-Rad Laboratories IncBio-Rad Laboratories IncBio-Rad Laboratories Inc among others.,